Biotech 2050 Podcast cover image

Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics

Biotech 2050 Podcast

CHAPTER

Introduction

David Esposito discusses his background, experiences in big pharma and early mid-stage life science companies, and provides an update on ONL Therapeutics' clinical trials.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner